|
US20040198706A1
(en)
*
|
2003-03-11 |
2004-10-07 |
Carrara Dario Norberto R. |
Methods and formulations for transdermal or transmucosal application of active agents
|
|
US8980290B2
(en)
|
2000-08-03 |
2015-03-17 |
Antares Pharma Ipl Ag |
Transdermal compositions for anticholinergic agents
|
|
US7198801B2
(en)
|
2000-08-03 |
2007-04-03 |
Antares Pharma Ipl Ag |
Formulations for transdermal or transmucosal application
|
|
CA2418135C
(en)
*
|
2000-08-03 |
2011-09-20 |
Antares Pharma Ipl Ag |
Novel composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels
|
|
PE20020300A1
(es)
*
|
2000-08-22 |
2002-05-10 |
Pharmacia Corp |
Composicion de solucion de un farmaco antibiotico a base de oxazolidinona con mejoramiento de la carga de farmaco
|
|
PE20020578A1
(es)
|
2000-10-10 |
2002-08-14 |
Upjohn Co |
Una composicion de antibiotico topico para el tratamiento de infecciones oculares
|
|
US6566556B2
(en)
*
|
2000-12-19 |
2003-05-20 |
Nippon Shokubai Co., Ltd. |
Method for production of alkanolamine and apparatus therefor
|
|
WO2003002152A2
(en)
*
|
2001-06-29 |
2003-01-09 |
Maxygen Aps |
Stabilized formulations of interferons with sulfoalkyl ether cyclodextrins
|
|
US7141540B2
(en)
*
|
2001-11-30 |
2006-11-28 |
Genta Salus Llc |
Cyclodextrin grafted biocompatible amphilphilic polymer and methods of preparation and use thereof
|
|
CA2470999C
(en)
*
|
2001-12-20 |
2017-02-21 |
Schering-Plough Corporation |
Syn3 compositions and methods
|
|
TW200400055A
(en)
*
|
2002-02-22 |
2004-01-01 |
Pharmacia Corp |
Ophthalmic formulation with novel gum composition
|
|
WO2003072141A1
(en)
*
|
2002-02-22 |
2003-09-04 |
Pharmacia Corporation |
Ophthalmic antibiotic drug formulations containing a cyclodextrin compound and cetyl pyridinium chloride
|
|
PT1670433E
(pt)
|
2003-10-10 |
2012-02-08 |
Ferring Bv |
Fórmula farmacológica transdérmica para a minimização de resíduos na pele
|
|
US8129346B2
(en)
|
2004-04-15 |
2012-03-06 |
Onyx Therapeutics, Inc. |
Compounds for enzyme inhibition
|
|
US8198270B2
(en)
*
|
2004-04-15 |
2012-06-12 |
Onyx Therapeutics, Inc. |
Compounds for proteasome enzyme inhibition
|
|
PT2030981E
(pt)
*
|
2004-05-10 |
2014-10-14 |
Onyx Therapeutics Inc |
Compostos para inibição da enzima proteassoma
|
|
CN102847136A
(zh)
*
|
2004-12-07 |
2013-01-02 |
普罗特奥里克斯公司 |
抑制蛋白酶体的组合物
|
|
WO2006125642A1
(en)
|
2005-05-27 |
2006-11-30 |
Antares Pharma Ipl Ag |
Methods and apparatus for transdermal or transmucosal application of testosterone
|
|
KR101434522B1
(ko)
|
2005-11-09 |
2014-08-26 |
오닉스 세라퓨틱스, 인크. |
효소 저해를 위한 화합물
|
|
US20070111965A1
(en)
*
|
2005-11-15 |
2007-05-17 |
Kipp James E |
Compositions comprising lipoxygenase inhibitors and cyclodextrin
|
|
US20070135586A1
(en)
*
|
2005-12-09 |
2007-06-14 |
Shreyas Chakravarti |
Polyamide blend compositions formed article and process thereof
|
|
NZ571460A
(en)
|
2006-04-21 |
2010-10-29 |
Antares Pharma Ipl Ag |
Methods of treating hot flashes with formulations for transdermal or transmucosal application
|
|
RU2450016C2
(ru)
*
|
2006-06-19 |
2012-05-10 |
Протеоликс, Инк. |
Пептидные эпоксикетоны для ингибирования протеасомы
|
|
US20090239942A1
(en)
*
|
2006-09-15 |
2009-09-24 |
Cloyd James C |
Topiramate Compositions and Methods of Making and Using the Same
|
|
PT2061458E
(pt)
*
|
2006-09-15 |
2015-03-11 |
Univ Minnesota |
Composições de topiramato e métodos para a sua utilização
|
|
EP2152078B8
(en)
|
2007-04-27 |
2021-03-17 |
CyDex Pharmaceuticals, Inc. |
Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use
|
|
WO2009018326A2
(en)
*
|
2007-07-31 |
2009-02-05 |
Limerick Biopharma, Inc. |
Soluble pyrone analogs methods and compositions
|
|
SI2207791T2
(sl)
*
|
2007-10-04 |
2019-09-30 |
Onyx Therapeutics, Inc. |
Kristalinični peptidepoksiketonski proteazni inhibitorji in sinteza aminokislinskih ketoepoksidov
|
|
US7635773B2
(en)
|
2008-04-28 |
2009-12-22 |
Cydex Pharmaceuticals, Inc. |
Sulfoalkyl ether cyclodextrin compositions
|
|
EP2303228B1
(en)
*
|
2008-05-19 |
2011-11-30 |
Texcontor Etablissement |
Fosphenytoin composition
|
|
EP2796134B1
(en)
|
2008-10-21 |
2016-12-07 |
Onyx Therapeutics, Inc. |
Combination of the peptide epoxyketone proteasome inhibitor carfilzomib with melphalan for use in the treatment of multiple myeloma
|
|
WO2010053487A1
(en)
|
2008-11-07 |
2010-05-14 |
Cydex Pharmaceuticals, Inc. |
Composition containing sulfoalkyl ether cyclodextrin and latanoprost
|
|
AR075899A1
(es)
|
2009-03-20 |
2011-05-04 |
Onyx Therapeutics Inc |
Tripeptidos epoxicetonas cristalinos inhibidores de proteasa
|
|
WO2010132711A1
(en)
*
|
2009-05-13 |
2010-11-18 |
Cydex Pharmaceuticals, Inc. |
Pharmaceutical compositions comprising prasugrel and cyclodextrin derivatives and methods of making and using the same
|
|
ES2767880T3
(es)
|
2009-05-29 |
2020-06-18 |
Cydex Pharmaceuticals Inc |
Composiciones inyectables de melfalán que comprenden un derivado de ciclodextrina y métodos de preparación y uso de las mismas
|
|
US11020363B2
(en)
|
2009-05-29 |
2021-06-01 |
Cydex Pharmaceuticals, Inc. |
Injectable nitrogen mustard compositions comprising a cyclodextrin derivative and methods of making and using the same
|
|
SMT201700430T1
(it)
|
2009-06-25 |
2018-01-11 |
Alkermes Pharma Ireland Ltd |
Composti eterociclici per il trattamento di disturbi neurologici e psicologici
|
|
NZ597108A
(en)
*
|
2009-06-25 |
2014-04-30 |
Alkermes Pharma Ireland Ltd |
Prodrugs of nh-acidic compounds
|
|
EP2498793B1
(en)
|
2009-11-13 |
2019-07-10 |
Onyx Therapeutics, Inc. |
Oprozomib for use in metastasis suppression
|
|
AU2011223795B2
(en)
|
2010-03-01 |
2015-11-05 |
Onyx Therapeutics, Inc. |
Compounds for immunoproteasome inhibition
|
|
KR20130094185A
(ko)
|
2010-04-07 |
2013-08-23 |
오닉스 세라퓨틱스, 인크. |
결정성 펩티드 에폭시케톤 면역프로테아좀 저해제
|
|
CA2802733C
(en)
|
2010-06-24 |
2017-11-21 |
Alkermes Pharma Ireland Limited |
Prodrugs of nh-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives
|
|
DE102011011028A1
(de)
*
|
2011-02-11 |
2012-08-16 |
Ditter Plastic Gmbh + Co. Kg |
Frontplatte mit darin eingespritztem Lichtleiter
|
|
HUE032109T2
(en)
|
2011-03-18 |
2017-08-28 |
Alkermes Pharma Ireland Ltd |
Injectable pharmaceutical compositions containing water insoluble antipsychotic, sorbitan laurate and polysorbate 20
|
|
HUE037575T2
(hu)
|
2011-09-18 |
2018-09-28 |
Euro Celtique Sa |
Gyógyászati kompozíció, amely tartalmaz egy HDAC (hiszton deacetiláz) inhibitort és egy ciklopoliszacharidot
|
|
US8969337B2
(en)
|
2011-12-15 |
2015-03-03 |
Alkermes Pharma Ireland Limited |
Prodrugs of secondary amine compounds
|
|
TWI573792B
(zh)
|
2012-02-01 |
2017-03-11 |
歐陸斯迪公司 |
新穎治療劑
|
|
ES2774901T3
(es)
|
2012-02-15 |
2020-07-23 |
Cydex Pharmaceuticals Inc |
Proceso para la fabricación de derivados de ciclodextrina
|
|
RU2615385C2
(ru)
|
2012-02-28 |
2017-04-04 |
Сидекс Фармасьютикалс, Инк. |
Композиции алкилированного циклодекстрина и способы их получения и применения
|
|
WO2013142205A1
(en)
|
2012-03-19 |
2013-09-26 |
Alkermes Pharma Ireland Limited |
Pharmaceutical compositions comprising benzyl alcohol
|
|
AU2013235523B9
(en)
|
2012-03-19 |
2018-01-04 |
Alkermes Pharma Ireland Limited |
Pharmaceutical compositions comprising glycerol esters
|
|
EP2827868B8
(en)
|
2012-03-19 |
2019-12-18 |
Alkermes Pharma Ireland Limited |
Pharmaceutical compositions comprising fatty acid esters
|
|
US20140105921A1
(en)
|
2012-07-09 |
2014-04-17 |
Onyx Therapeutics, Inc. |
Prodrugs of Peptide Epoxy Ketone Protease Inhibitors
|
|
ES2792149T3
(es)
|
2012-09-19 |
2020-11-10 |
Alkermes Pharma Ireland Ltd |
Composiciones farmacéuticas que tienen estabilidad de almacenamiento mejorada
|
|
AU2013334921B2
(en)
|
2012-10-22 |
2018-03-29 |
Cydex Pharmaceuticals, Inc. |
Alkylated cyclodextrin compositions and processes for preparing and using the same
|
|
WO2015143145A1
(en)
|
2014-03-20 |
2015-09-24 |
Alkermes Pharma Ireland Limited |
Aripiprazole formulations having increased injection speeds
|
|
GB201409471D0
(en)
|
2014-05-28 |
2014-07-09 |
Euro Celtique Sa |
Pharmaceutical composition
|
|
GB201409488D0
(en)
|
2014-05-28 |
2014-07-09 |
Euro Celtique Sa |
Pharmaceutical composition
|
|
GB201409485D0
(en)
|
2014-05-28 |
2014-07-09 |
Euro Celtique Sa |
Pharmaceutical composition
|
|
US10851184B2
(en)
|
2014-08-22 |
2020-12-01 |
Cydex Pharmaceuticals, Inc. |
Fractionated alkylated cyclodextrin compositions and processes for preparing and using the same
|
|
GB201609222D0
(en)
|
2016-05-25 |
2016-07-06 |
F2G Ltd |
Pharmaceutical formulation
|
|
WO2018068832A1
(en)
|
2016-10-11 |
2018-04-19 |
Euro-Celtique S.A. |
Hodgkin lymphoma therapy
|
|
GB201709403D0
(en)
|
2017-06-13 |
2017-07-26 |
Euro Celtique Sa |
Compounds for treating sarcoma
|
|
GB201709402D0
(en)
|
2017-06-13 |
2017-07-26 |
Euro Celtique Sa |
Compounds for treating t-pll
|
|
GB201709406D0
(en)
|
2017-06-13 |
2017-07-26 |
Euro-Cletique S A |
Compounds for treating TNBC
|
|
GB201709405D0
(en)
|
2017-06-13 |
2017-07-26 |
Euro Celtique Sa |
Compounds for treating ovarian cancer
|
|
US11273158B2
(en)
|
2018-03-05 |
2022-03-15 |
Alkermes Pharma Ireland Limited |
Aripiprazole dosing strategy
|
|
EP3897626B1
(en)
|
2018-12-18 |
2025-09-10 |
Mundipharma International Corporation Limited |
Tinostamustine for treating multiple myeloma
|
|
US11819503B2
(en)
|
2019-04-23 |
2023-11-21 |
F2G Ltd |
Method of treating coccidioides infection
|
|
CN110279664B
(zh)
*
|
2019-07-30 |
2021-09-03 |
四川农业大学 |
一种氟苯尼考包合物冻干粉针剂及其制备方法
|
|
WO2021026310A1
(en)
|
2019-08-06 |
2021-02-11 |
L.E.A.F. Holdings Group Llc |
Processes of preparing polyglutamated antifolates and uses of their compositions
|
|
CA3198795A1
(en)
|
2020-11-18 |
2022-05-27 |
Jeffrey Becker |
Complexing agent salt formulations of pharmaceutical compounds
|
|
CN114588116B
(zh)
*
|
2020-12-04 |
2024-03-15 |
四川科瑞德制药股份有限公司 |
磷苯妥英钠固体组合物、冻干方法、及其用途
|
|
AU2020480182B2
(en)
*
|
2020-12-04 |
2025-02-27 |
Sichuan Credit Pharmaceutical Co., Ltd |
Fosphenytoin sodium solid composition, lyophilization method, and use of fosphenytoin sodium solid composition
|
|
EP4525916A1
(en)
*
|
2022-05-18 |
2025-03-26 |
Bexson Biomedical, Inc. |
Complexing agent salt formulations of pharmaceutical compounds at low stoichiometric ratios
|
|
WO2024231293A1
(en)
|
2023-05-05 |
2024-11-14 |
Euro-Celtique S.A. |
Combinations for treating cancer
|